Vaxart to Host Upcoming Conference Calls
Vaxart (OTCQX: VXRT) will host two investor webcasts in November 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Vaxart (OTCQX: VXRT) will host two investor webcasts in November 2025. Management will report third quarter 2025 financial results after market close on Thursday, November 13, 2025 and hold a conference call at 4:30 p.m. ET. A stockholder fireside chat is scheduled for Tuesday, November 18, 2025 at 4:30 p.m. ET / 1:30 p.m. PT to answer shareholder questions.
Both events will be webcast on the company website and replayed afterward. Investors can call in using the provided domestic and international numbers for the Nov. 13 call, and may submit questions in advance to ir@vaxart.com or via the webcast portal.
Details
News Market Reaction – VXRT
On Nov 7, the day this news came out, VXRT closed 7.19% above the previous close.
Data tracked by StockTitan Argus for the Nov 7 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Third quarter 2025 results conference call to be held on November 13 at 4:30 p.m. ET
Stockholder fireside chat to be held on November 18 at 4:30 p.m. ET
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”) today announced it will host two upcoming webcast conference calls.
Third Quarter 2025 Financial Results
Vaxart will provide a business update and report financial results for the third quarter ended September 30, 2025, after the market close on Thursday, November 13, 2025. The Vaxart senior management team will host a conference call on the same day, beginning at 4:30 p.m. ET.
The third quarter financial results conference call can be accessed using the following information:
Webcast: Click here
Date: Thursday, November 13, 2025 – 4:30 p.m. ET
Domestic: (877) 407-0832
International: (201) 689-8433
Conference ID: 13756391
Stockholder Fireside Chat
Members of Vaxart’s senior management team will participate in a virtual fireside chat on Tuesday, November 18, 2025 at 4:30 p.m. ET / 1:30 p.m. PT as part of its regular series to answer frequently asked questions from its stockholders.
A live webcast of the fireside chat will be available on the Company’s website at www.vaxart.com or by clicking here.
Investors may submit written questions in advance of the conference call to ir@vaxart.com or through the webcast portal.
A replay of the third quarter financial results and stockholder fireside chat webcasts will be available on the Company’s website at www.vaxart.com following the conclusion of the events.
About Vaxart
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart’s development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Contact
Vaxart Media and Investor Relations
Matt Steinberg
FINN Partners
IR@vaxart.com
(646) 871-8481
This press release was published by a CLEAR® Verified individual.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.